LOCAL AFFILIATE PRODUCT SERVICES

Ensure global consistency with local QPPV services

End-to-end safety-focused Local Qualified Person for Pharmacovigilance (LQPPV) services and latest PV/MI technologies, ensure global consistency at a local country level and compliance with all local safety requirements. 

WORLDWIDE, LOCAL PHARMACOVIGILANCE

Local Affiliate Product Services

With over 4,000 professionals worldwide and over 600 country-based staff, IQVIA’s robust safety organization can provide end-to-end solutions with regulatory-focused medical experts and leading technologies to support your local safety needs.

Our end-to-end Local Affiliate Product Services (LAPS), with safety-focused industry experts and latest technologies, ensure global consistency at a local country level and compliance with all local safety requirements. From single country, regional, to full international support, the IQVIA LAPS model allows customers to build a robust LQPPV strategy that fits their needs while driving operational and budgetary efficiencies.

Local Affiliate Product Services FAQs

Supporting confident LQPPV and local pharmacovigilance decisions

IQVIA Local Affiliate Product Services (LAPS) are end to end services that support local pharmacovigilance and medical information activities, helping companies staying complaint with country-specific safety and regulatory requirements.

LAPS combines global consistency with local expertise, ensuring that global standards are applied effectively at the local level while meeting national regulations and operational needs.

LAPS includes local pharmacovigilance and medical information services including (but not limited to) adverse event intake, ICSR management, local literature search, medical information call center support, and access to regulatory intelligence needed for local compliance.
A Local Qualified Person for Pharmacovigilance (LQPPV) serves as the Marketing Authorization Holder’s local representative and primary contact with national health authorities, making the role essential for maintaining local pharmacovigilance and regulatory compliance.
As pharmacovigilance requirements become more complex, many organizations consider outsourcing LQPPV to manage regulatory complexity more effectively. This approach provides access to local expertise, flexible and scalable resources, and consistent oversight while reducing internal operational management burden.
“An integrated approach to global and local PV and MI is needed to streamline operations and ensure a comprehensive view of information to enhance patient safety overall.”
Barry Mulchrone
Head of Safety Science & Strategy, Lifecycle Safety
Go further with Local Affiliate Product Services
Our end-to-end Local Affiliate Product Services (LAPS), with safety-focused industry experts and latest technologies, ensure global consistency at a local country level and compliance with all local safety requirements.
From single country, regional, to full international support, the IQVIA LAPS model allows customers to build a strategy that fits their needs while driving operational and budgetary efficiencies.

Additional answers to your LAPS questions

Operational scale, compliance, and long term flexibility

LAPS supports local compliance by combining globally aligned pharmacovigilance standards with in-country regulatory expertise. This ensures that local affiliate activities follow consistent global processes while remaining fully compliant with country-specific safety and regulatory requirements.
LAPS helps organizations meet local regulatory requirements with confidence, scale pharmacovigilance operations without increasing internal headcount, and drive operational and budgetary efficiencies across local affiliates, while maintaining consistent global oversight.
Yes. LAPS is designed to support single country, regional, or full global models, allowing organizations to start where support is needed (e.g. LQPPV) and scale over time as their portfolio or geographic footprint expands.
At the local level, LAPS supports key operational pharmacovigilance activities designed to meet country‑specific requirements. These include, but not limited to, adverse event intake, local case management, medical information services, and regulatory focused safety support aligned with local authority expectations.
AI can augment the LQPPV role by improving efficiency across pharmacovigilance workflows, such as supporting data management, signal detection, and regulatory reporting. However, human oversight, local accountability, and regulatory judgment remain essential, making AI a complement to the LQPPV role rather than a replacement.
Yes. LAPS enables emerging and mid‑size companies to meet local pharmacovigilance and regulatory requirements even without an existing local affiliate structure, offering a scalable solution that can evolve as the organization grows.
IQVIA’s LAPS offering is supported by a global, end-to-end safety organization, comprising thousands of professionals worldwide, with dedicated country based staff supporting local execution across more than 170 countries and multiple languages, ensuring both global scale and strong local expertise.
IQVIA has provided tailored local affiliate safety and medical information solutions for more than 15 years across global markets.

Related Solutions

Contact Us